6. AOACSPIFANMethods-2018Awards

239

F eng et al .: J ournal of AOAC I nternational V ol . 100, N o . 2, 2017  521

Acknowledgments

Recommended Guidelines for Stakeholder Panel on Infant Formula and Adult Nutritionals (SPIFAN) Single-Laboratory Validation (2) (January 2014) Application Guide, PA 800 Plus Pharmaceutical Analysis System, Part No. A51970AD, Beckman Coulter, Inc., Fullerton, CA (3) Rudloff, S., & Lönnerdal, B. (1992) J. Pediatr. Gastroenterol. Nutr. 15 , 25–33. doi:10.1097/00005176- 199207000-00005 (4) Walstra, P., Wouters, J.T.M., & Geurts, T.J. (2005) Dairy Science and Technology , 2nd Ed., CRC Press, Boca Raton, FL (5) Koletzko, B., Baker, S., Cleghorn, G., Neto, U.F., Gopalan, S., Hernell, O., Hock, Q.S., Jirapinyo, P., Lonnerdal, B., Pencharz, P., Pzyrembel, H., Ramirez- Mayans, J., Shamir, R., Turck, D., Yamashiro, Y., & Zong-Yi, D. (2005)  J. Ped. Gastroenterol. Nutr. 41 , 584–599, Table 3

We thank Hongxu Chen and Jianhua Wu (AB Sciex) for providing the PA 800 Plus instrument and instrument maintenance, Chao Wu (Hilmar Ingredients) for helping us understand the meaning of split peaks for infant formula proteins, Longfei Wang (Nestlé Food Safety Institute, Beijing) for providing the laboratory facilities, and Wyeth Nutrition Suzhou for supplying pilot-scale placebo infant formula samples and samples with different protein ingredients.

References

(1) Official Methods of Analysis (2012) 19th Ed., AOAC INTERNATIONAL, Rockville, MD, Appendix L: AOAC